In contrast, patients with GBM, which demonstrated reduced PSMD1 expression compared with normal controls (Figure 1A), were associated with structural variants and deep deletions (Figure 3A), possibly explaining the reduced expression observed in this particular type of cancer. This evidence concerns the gene PSMD1 and glioblastoma.